Stock listing
Molecure Sa
Selected listing: A2JJ69 · LS · EUR · DE
Molecure Sa (Lang & Schwarz: A2JJ69), Health Technology. Latest release Aug 3, 2026: Molecure Receives Positive IDMC Recommendation to Continue the KITE…
- Ticker
- Lang & Schwarz: A2JJ69
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Molecure Sa
Molecure Receives Positive IDMC Recommendation to Continue the KITE Clinical Trial Without Changes to the Study Protocol (OATD-01 Development Program)
August 3, 2026
Strategic update on the progress and development of Molecure's key clinical projects in 2024
March 28, 2025
Avicenna Biosciences and Molecure S.A. Sign Strategic Research Collaboration Agreement to Accelerate Discovery and Development of Small Molecule Drugs
July 31, 2024
Molecure Announces Details for Virtual R&D Day Webcast to be held on Wednesday 7th December 2022
December 6, 2022
Research Molecure Sa
Alternate listings
MOC:GPW
PL · PLN
Alternate listing for Molecure Sa; the primary context on this page is A2JJ69:LS.
A2JJ69:LSX
DE · EUR
Alternate listing for Molecure Sa; the primary context on this page is A2JJ69:LS.
1B1:GETTEX
DE · EUR
Alternate listing for Molecure Sa; the primary context on this page is A2JJ69:LS.
1B1:FWB
DE · EUR
Alternate listing for Molecure Sa; the primary context on this page is A2JJ69:LS.
1B1:MUN
DE · EUR
Alternate listing for Molecure Sa; the primary context on this page is A2JJ69:LS.
1B1:SWB
DE · EUR
Alternate listing for Molecure Sa; the primary context on this page is A2JJ69:LS.